000279508 001__ 279508
000279508 005__ 20250820091945.0
000279508 0247_ $$2doi$$a10.5281/ZENODO.14893737
000279508 0247_ $$2doi$$a10.5281/zenodo.14893737
000279508 0247_ $$2doi$$a10.5281/zenodo.14893736
000279508 037__ $$aDZNE-2025-00835
000279508 1001_ $$0P:(DE-2719)9002103$$aLee, Jaehyun$$b0
000279508 245__ $$aDataset: snRNA data of Brain section from Parkinson Mouse Model based on inducible expression of human a-syn constructs, v1
000279508 260__ $$bZenodo$$c2025
000279508 3367_ $$2BibTeX$$aMISC
000279508 3367_ $$0PUB:(DE-HGF)32$$2PUB:(DE-HGF)$$aDataset$$bdataset$$mdataset$$s1752047038_8070
000279508 3367_ $$026$$2EndNote$$aChart or Table
000279508 3367_ $$2DataCite$$aDataset
000279508 3367_ $$2ORCID$$aDATA_SET
000279508 3367_ $$2DINI$$aResearchData
000279508 520__ $$aUsing 6-months, 16-months, and 24-months old mice of a inducible expression of human a-syn constructs based Parkinson mouse model, we produced a single nucleus RNA dataset by cutting 0mm Bregma to -5mm Bregma. The Chromium 3’ Single Cell Library Kit (10x Genomics) was used and Sequencing was performed on a NovaSeq 6000. Paired 150bp snRNA-seq was performed using the 10X Genomics Gene Expression (GEX) 3´protocol with an NovaSeq 6000 sequencer. For the alignment of reads, a custom reference was created by adding the sequences of the S1/S2 transgene and the CamkIIa promoter to the mm10 mouse reference genome. Count matrices were obtained using the cellranger count 7.1 pipeline, including introns. Six samples were mapped using the bwUni2.0 High-Performance Computing infrastructure. The unfiltered count matrices were loaded into R and corrected for ambient mRNA using SoupX 1.6.0 with default settings, adjusting “tfidfMin” settings between 0.9 and 1.3 depending on the sample. Seurat objects were created for each sample and subsequently merged. Cells were filtered out based on the following criteria: number of unique molecular identifiers (nUMI) 3%, ribosomal gene percentage > 1.5%, or log10(Genes/nUMI)
000279508 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000279508 588__ $$aDataset connected to DataCite
000279508 7001_ $$0P:(DE-2719)9001513$$aDanzer, Karin$$b1
000279508 773__ $$a10.5281/zenodo.14893737
000279508 909CO $$ooai:pub.dzne.de:279508$$pVDB
000279508 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9002103$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000279508 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9001513$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000279508 9141_ $$y2025
000279508 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000279508 9201_ $$0I:(DE-2719)5000072$$kAG Danzer$$lMechanisms of Propagation$$x0
000279508 980__ $$adataset
000279508 980__ $$aVDB
000279508 980__ $$aI:(DE-2719)5000072
000279508 980__ $$aUNRESTRICTED